Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2500 participants
OBSERVATIONAL
2024-01-31
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Construction of Gynecological Tumor Organoids
NCT06155370
Clinical Database and Biobank of Patients With Gynecologic Neoplasms
NCT01267851
Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study
NCT04214964
Comprehensive Study on the Quality of Life in Cervical Cancer Patients
NCT03967457
The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor
NCT02166515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
samples of cervical cancer
fresh samples collected from patients diagnosed with cervical cancer
No interventions assigned to this group
samples of endometrial cancer
fresh samples collected from patients diagnosed with endometrial cancer
No interventions assigned to this group
samples of ovarian cancer
fresh samples collected from patients diagnosed with ovarian cancer
No interventions assigned to this group
samples of vulva cancer
fresh samples collected from patients diagnosed with vulva cancer
No interventions assigned to this group
samples of vaginal cancer
fresh samples collected from patients diagnosed with vaginal cancer
No interventions assigned to this group
samples of rare gynecological cancer
fresh samples collected from patients diagnosed with rare gynecological cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Preoperative tumor burden assessment and intraoperative evaluation by the supervising physician (professor) suggest sampling is acceptable.
3. The research team believes that sampling is possible.
4. Having the relevant requirements for sample library storage.
5. Surgical treatment is performed at Peking Union Medical College Hospital.
2. The research team considers any circumstances or considerations that may hinder normal pathological evaluation.
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Construction of tumor sample
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.